Roger Jeffs sold Liquidia Corp ($LQDA) shares on the open market six times over the last year, totaling about $4.3 million, with his most recent sale on January 12, 2026. He ranks 2,164th among nearly 12,000 insiders for $LQDA sales volume. He also sold Axsome Therapeutics ($AXSM) shares six times, worth roughly $13.4 million, most recently on September 2, 2025, placing 912th in $AXSM sales. These transactions match the average insider sale count of about six but exceed the typical $8.6 million value. Jeffs made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 16, 2026 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | A | Common Stock | 115344 | $0.00 | 2,741,134.0000 | 86,059,101 | 4.39% | 0.13% |
| Jan. 16, 2026 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | A | Performance Stock Units | 173016 | $0.00 | 173,016.0000 | 86,059,101 | 9999.99% | 0.20% |
| Jan. 9, 2026 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | M | Common Stock | 13833 | $0.00 | 2,635,068.0000 | 86,059,101 | 0.53% | 0.02% |
| Jan. 9, 2026 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | M | Common Stock | 57332 | $0.00 | 2,692,400.0000 | 86,059,101 | 2.18% | 0.07% |
| Jan. 9, 2026 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | M | Performance Stock Units | 57332 | $0.00 | 171,995.0000 | 86,059,101 | 25.00% | 0.07% |
| Jan. 9, 2026 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | M | Performance Stock Units | 13833 | $0.00 | 110,669.0000 | 86,059,101 | 11.11% | 0.02% |
| Jan. 12, 2026 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | S | Common Stock | 66610 | $37.43 | 2,625,790.0000 | 86,059,101 | 2.47% | 0.08% |
| Oct. 13, 2025 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | S | Common Stock | 20261 | $23.41 | 2,621,235.0000 | 86,333,772 | 0.77% | 0.02% |
| Oct. 10, 2025 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | M | Common Stock | 13834 | $0.00 | 2,641,496.0000 | 86,333,772 | 0.53% | 0.02% |
| Oct. 10, 2025 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | M | Performance Stock Units | 13834 | $0.00 | 124,502.0000 | 86,333,772 | 10.00% | 0.02% |
| Sept. 2, 2025 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Not found | S | Common Stock | 13464 | $123.68 | 57,510.0000 | 48,765,403 | 18.97% | 0.03% |
| Aug. 28, 2025 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Not found | S | Common Stock | 20000 | $121.60 | 90,974.0000 | 48,765,403 | 18.02% | 0.04% |
| Aug. 27, 2025 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Not found | S | Common Stock | 20000 | $122.30 | 110,974.0000 | 48,765,403 | 15.27% | 0.04% |
| Aug. 29, 2025 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Not found | S | Common Stock | 20000 | $121.27 | 70,974.0000 | 48,765,403 | 21.98% | 0.04% |
| Aug. 22, 2025 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Not found | S | Common Stock | 16694 | $120.08 | 150,974.0000 | 48,765,403 | 9.96% | 0.03% |
| Aug. 26, 2025 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Not found | S | Common Stock | 20000 | $120.03 | 130,974.0000 | 48,765,403 | 13.25% | 0.04% |
| July 11, 2025 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | M | Performance Stock Units | 13833 | $0.00 | 138,336.0000 | 85,588,108 | 9.09% | 0.02% |
| July 11, 2025 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | M | Common Stock | 13833 | $0.00 | 2,647,074.0000 | 85,588,108 | 0.53% | 0.02% |
| July 14, 2025 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | S | Common Stock | 20252 | $14.28 | 2,626,822.0000 | 85,588,108 | 0.77% | 0.02% |
| July 11, 2025 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | M | Common Stock | 13833 | $0.00 | 2,647,074.0000 | 85,588,108 | 0.53% | 0.02% |
| July 11, 2025 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | M | Performance Stock Units | 13833 | $0.00 | 138,336.0000 | 85,588,108 | 9.09% | 0.02% |
| July 14, 2025 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | S | Common Stock | 20252 | $14.28 | 2,626,822.0000 | 85,588,108 | 0.77% | 0.02% |
| June 6, 2025 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Not found | A | Stock Option (Right to Buy) | 3166 | $0.00 | 3,166.0000 | 48,765,403 | 9999.99% | 0.01% |
| June 6, 2025 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Not found | A | Restricted Stock Units | 1429 | $0.00 | 1,429.0000 | 48,765,403 | 9999.99% | 0.00% |
| June 4, 2025 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | S | Common Stock | 30610 | $16.97 | 2,633,241.0000 | 85,172,696 | 1.15% | 0.04% |
| June 3, 2025 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | M | Common Stock | 69169 | $0.00 | 2,663,851.0000 | 85,172,696 | 2.67% | 0.08% |
| June 3, 2025 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | M | Performance Stock Units | 69169 | $0.00 | 152,169.0000 | 85,172,696 | 31.25% | 0.08% |
| April 14, 2025 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | S | Common Stock | 14130 | $13.57 | 2,594,682.0000 | 85,172,696 | 0.54% | 0.02% |
| Feb. 21, 2025 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Not found | A | Stock Option (Right to Buy) | 1408 | $0.00 | 1,408.0000 | 48,765,403 | 9999.99% | 0.00% |
| Jan. 11, 2025 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | A | Performance Stock Units | 229327 | $0.00 | 229,327.0000 | 78,707,503 | 9999.99% | 0.29% |
| Jan. 11, 2025 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | A | Common Stock | 229327 | $0.00 | 2,629,782.0000 | 78,707,503 | 9.55% | 0.29% |
| Jan. 14, 2025 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | S | Common Stock | 22343 | $11.78 | 2,607,439.0000 | 78,707,503 | 0.85% | 0.03% |
| Oct. 14, 2024 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | S | Common Stock | 8053 | $11.11 | 2,400,455.0000 | 78,316,820 | 0.33% | 0.01% |
| July 12, 2024 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | S | Common Stock | 8053 | $12.53 | 2,407,194.0000 | 76,435,831 | 0.33% | 0.01% |
| June 7, 2024 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Not found | A | Stock Option (Right to Buy) | 5799 | $0.00 | 5,799.0000 | 0 | 9999.99% | 0.00% |
| April 12, 2024 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | S | Common Stock | 8360 | $14.58 | 2,415,247.0000 | 75,393,907 | 0.34% | 0.01% |
| March 18, 2024 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | S | Common Stock | 28583 | $15.82 | 2,423,607.0000 | 64,993,476 | 1.17% | 0.04% |
| March 15, 2024 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Not found | M | Common Stock | 2347 | $29.91 | 170,015.0000 | 0 | 1.40% | 0.00% |
| March 15, 2024 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Not found | M | Stock Option (Right to Buy) | 2347 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 14, 2024 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Not found | M | Stock Option (Right to Buy) | 16976 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 14, 2024 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Not found | M | Stock Option (Right to Buy) | 13000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 15, 2024 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Not found | S | Common Stock | 2347 | $71.61 | 167,668.0000 | 0 | 1.38% | 0.00% |
| March 14, 2024 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Not found | M | Common Stock | 13000 | $22.03 | 180,668.0000 | 0 | 7.75% | 0.00% |
| March 14, 2024 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Not found | S | Common Stock | 13000 | $69.70 | 167,668.0000 | 0 | 7.20% | 0.00% |
| March 14, 2024 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Not found | M | Common Stock | 16976 | $25.53 | 184,644.0000 | 0 | 10.12% | 0.00% |
| March 14, 2024 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Not found | S | Common Stock | 16976 | $69.70 | 167,668.0000 | 0 | 9.19% | 0.00% |
| Feb. 27, 2024 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Not found | A | Stock Option (Right to Buy) | 1425 | $0.00 | 1,425.0000 | 0 | 9999.99% | 0.00% |
| Jan. 11, 2024 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | A | Performance Stock Units | 221338 | $0.00 | 221,338.0000 | 64,993,476 | 9999.99% | 0.34% |
| Jan. 11, 2024 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | A | Common Stock | 221338 | $0.00 | 2,450,405.0000 | 64,993,476 | 9.93% | 0.34% |
| Dec. 14, 2023 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | P | Common Stock | 139665 | $7.16 | 2,229,067.0000 | 64,857,508 | 6.68% | 0.22% |
| June 2, 2023 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Director | A | Stock Option (Right to Buy) | 5681 | $0.00 | 5,681.0000 | 0 | 9999.99% | 0.00% |
| Aug. 31, 2022 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | A | Common Stock | 993 | $4.90 | 1,704,269.0000 | 62,179,305 | 0.06% | 0.00% |
| March 2, 2023 | Axsome Therapeutics, Inc. | $AXSM | JEFFS ROGER | Director | A | Stock Option (Right to Buy) | 2082 | $0.00 | 2,082.0000 | 0 | 9999.99% | 0.00% |
| Jan. 11, 2023 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | A | Stock Option (Right to Buy) | 371154 | $0.00 | 371,154.0000 | 60,958,862 | 50.00% | 0.61% |
| Jan. 11, 2023 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | A | Common Stock | 289500 | $0.00 | 2,085,011.0000 | 60,958,862 | 16.12% | 0.47% |
| Jan. 3, 2023 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | M | Restricted Stock Unit | 15807 | $0.00 | 0.0000 | 60,958,862 | 100.00% | 0.03% |
| Jan. 3, 2023 | Liquidia Corp | $LQDA | JEFFS ROGER | Chief Executive Officer | M | Common Stock | 15807 | $0.00 | 1,795,511.0000 | 60,958,862 | 0.89% | 0.03% |